CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · IEX Real-Time Price · USD

1.320

-0.010 (-0.75%)

At close: Jul 2, 2024, 4:00 PM

1.260

-0.060 (-4.55%)

After-hours: Jul 2, 2024, 7:39 PM EDT

CytomX Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-0.57	-99.32	-115.87	-64.82	-132.83	Upgrade
Depreciation & Amortization	5.9	5.86	5.84	5.46	5.28	Upgrade
Share-Based Compensation	8.56	13.13	13.17	14.79	19.1	Upgrade
Other Operating Activities	-69.93	-30.45	-22.17	49.83	-32.03	Upgrade
Operating Cash Flow	-56.04	-110.79	-119.03	5.26	-140.48	Upgrade
Capital Expenditures	-0.84	-1.74	-1.61	-2.31	-3.5	Upgrade
Change in Investments	-149.83	100	24.1	-16.41	83.2	Upgrade
Investing Cash Flow	-150.67	98.26	22.49	-18.72	79.7	Upgrade
Share Issuance / Repurchase	30.23	0.65	110.21	16.89	1.63	Upgrade
Financing Cash Flow	30.23	0.65	110.21	16.89	1.63	Upgrade
Net Cash Flow	-176.48	-11.88	13.67	3.43	-59.15	Upgrade
Free Cash Flow	-56.88	-112.53	-120.64	2.95	-143.98	Upgrade
Free Cash Flow Margin	-56.19%	-211.67%	-323.33%	4.31%	-535.19%	Upgrade
Free Cash Flow Per Share	-0.77	-1.71	-1.88	0.06	-3.18	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).